Before revision: Alzheimer's disease A recent study showed that plasma biomarkers have the potential to be used as surrogate biomarkers in Alzheimer ’ s disease (AD) clinical trials.
After revision: Alzheimer's disease A recent study showed that plasma biomarkers have the potential to be used as surrogate biomarkers in Alzheimer ' s disease (AD) clinical trials.